RU2351332C2 - Порошкообразная антацидная фармацевтическая композиция, содержащий ее фармацевтический препарат и способ ее получения - Google Patents

Порошкообразная антацидная фармацевтическая композиция, содержащий ее фармацевтический препарат и способ ее получения Download PDF

Info

Publication number
RU2351332C2
RU2351332C2 RU2007120753/15A RU2007120753A RU2351332C2 RU 2351332 C2 RU2351332 C2 RU 2351332C2 RU 2007120753/15 A RU2007120753/15 A RU 2007120753/15A RU 2007120753 A RU2007120753 A RU 2007120753A RU 2351332 C2 RU2351332 C2 RU 2351332C2
Authority
RU
Russia
Prior art keywords
composition
sodium alginate
composition according
antacid
proton pump
Prior art date
Application number
RU2007120753/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2007120753A (ru
Inventor
Марио Атилио ЛОС (AR)
Марио Атилио Лос
Original Assignee
Лабораториос Баго С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лабораториос Баго С.А. filed Critical Лабораториос Баго С.А.
Publication of RU2007120753A publication Critical patent/RU2007120753A/ru
Application granted granted Critical
Publication of RU2351332C2 publication Critical patent/RU2351332C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2007120753/15A 2006-06-05 2007-06-04 Порошкообразная антацидная фармацевтическая композиция, содержащий ее фармацевтический препарат и способ ее получения RU2351332C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP20060102333 2006-06-05
ARP060102333A AR056062A1 (es) 2006-06-05 2006-06-05 Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion

Publications (2)

Publication Number Publication Date
RU2007120753A RU2007120753A (ru) 2008-12-10
RU2351332C2 true RU2351332C2 (ru) 2009-04-10

Family

ID=38572778

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007120753/15A RU2351332C2 (ru) 2006-06-05 2007-06-04 Порошкообразная антацидная фармацевтическая композиция, содержащий ее фармацевтический препарат и способ ее получения

Country Status (11)

Country Link
US (2) US7968118B2 (es)
EP (1) EP1905426B1 (es)
AR (1) AR056062A1 (es)
BR (1) BRPI0704028B8 (es)
DE (1) DE07380159T1 (es)
ES (1) ES2301455T3 (es)
MX (1) MX2007006722A (es)
PL (1) PL1905426T3 (es)
RU (1) RU2351332C2 (es)
UA (1) UA95224C2 (es)
UY (1) UY30382A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
WO2011131203A2 (en) 2010-04-23 2011-10-27 S-Biotek Holding Aps A solid pharmaceutical composition for neutralizing stomach acid
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
TR201723199A2 (tr) * 2017-12-30 2019-07-22 Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi Yeni farmasötik bileşimler.
TW202126301A (zh) 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物
FR3107183B1 (fr) * 2020-02-19 2022-04-29 Amsellem Jean Paul Composition pour le traitement des vertiges
CN114288243B (zh) * 2022-01-24 2023-02-07 中国药科大学 一种口服抗酸原位凝胶及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
AU5446798A (en) * 1996-11-27 1998-06-22 Procter & Gamble Company, The Compositions and methods for the treatment of gastrointestinal disorders
BR0300882A (pt) * 2003-04-09 2005-05-10 Cmax Otimizacao De Resultados Composições farmacêuticas, método e uso de formulação para tratamento e prevenção de infecções associadas com helicobacter pylori em mamìferos e no ser humano
WO2005007117A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
WO2005032554A1 (en) * 2003-10-03 2005-04-14 Astron Research Pvt. Ltd A novel transmucosal delivery system

Also Published As

Publication number Publication date
AR056062A1 (es) 2007-09-19
EP1905426B1 (en) 2012-09-05
DE07380159T1 (de) 2008-08-21
PL1905426T3 (pl) 2013-02-28
RU2007120753A (ru) 2008-12-10
UY30382A1 (es) 2007-07-31
US7968118B2 (en) 2011-06-28
ES2301455T3 (es) 2013-01-23
US8093271B2 (en) 2012-01-10
BRPI0704028B8 (pt) 2022-05-10
MX2007006722A (es) 2009-02-18
BRPI0704028B1 (pt) 2021-02-09
ES2301455T1 (es) 2008-07-01
UA95224C2 (ru) 2011-07-25
US20070281015A1 (en) 2007-12-06
BRPI0704028A (pt) 2008-04-01
EP1905426A2 (en) 2008-04-02
EP1905426A3 (en) 2008-05-21
US20100160382A1 (en) 2010-06-24

Similar Documents

Publication Publication Date Title
RU2351332C2 (ru) Порошкообразная антацидная фармацевтическая композиция, содержащий ее фармацевтический препарат и способ ее получения
TWI478735B (zh) 包含質子幫浦抑制劑之固體劑型及由其所製得之懸浮物
RU2441648C2 (ru) Композиции частиц, включающие альгинат и/или альгиновую кислоту
US20050053655A1 (en) Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
PT2258351E (pt) Grânulos contendo lansoprazole em grande quantidade
ES2668203T3 (es) Microcápsulas de fexofenadina y composiciones que las contienen
JPH08503482A (ja) 部分水素添加植物油で被覆されたシメチジン顆粒剤
CN112755014A (zh) 双氯芬酸制剂和使用方法
JPH01313420A (ja) 医薬咀しゃく錠組成物
CN106068120B (zh) 使用射频和有损耗的包衣粒子制造片剂的方法
RU2248794C2 (ru) Комбинации, содержащие цефуроксимаксетил
JP2013028603A (ja) プロトンポンプ阻害剤の液体剤形
US20040081700A1 (en) Dose titratable liquid dosage forms of acid labile drugs
EP1891936A1 (de) Gut schluckbare pharmazeutische Zusammensetzung aus einem oder mehreren wirkstoffhaltigen Teilchen ohne unangenehmes Mundgefühl
TW200526270A (en) Controlled release dosage forms of azithromycin
Kumar et al. Fast dissolving tablets: patient compliance dosage forms
US11833251B2 (en) Pharmaceutical methods and compositions
AU2006341307B2 (en) Particulate compositions comprising alginate and/or alginic acid
JP6832195B2 (ja) 経口液剤及び経口固形剤
CA3153555A1 (en) Pediatric suspension formulation